A Multiple-dose, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dysport for the Treatment of Pain Associated With Hallux Abducto Valgus
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms DYSTANCE
- Sponsors Ipsen
- 25 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2019 Planned primary completion date changed from 14 Jan 2020 to 3 Feb 2020.
- 01 Mar 2019 Planned End Date changed from 22 Nov 2019 to 23 Jun 2020.